Elon Musk's brain-implant company Neuralink input $280 million in a round led by Peter Thiel-backed Founders Fund, the company tweeted.
Why it matters: Neuralink recently bagged FDA approval for human clinical trials, despite being the subject of several current and potential federal probes regarding its treatment of animals, transport of pathogens and allegedly rushed project timelines.
